Casi Pharmaceuticals Stock Price, News & Analysis
Company Description
Casi Pharmaceuticals (OTC Link: CASIF) is a publicly traded company.
CASIF stock has declined 54.7% over the past year. Shares last traded at $0.1100.
On a trailing twelve-month basis, Casi Pharmaceuticals reported revenue of $20.7M with net income of -$48.1M and diluted earnings per share of $-2.59. The company operates at a net profit margin of -232.0%.
This page provides a comprehensive overview of CASIF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Casi Pharmaceuticals (CASIF) stock last traded at $0.1100. Over the past 12 months, the stock has lost 54.7%.
CASIF Rankings
Latest News
SEC Filings
Casi Pharmaceuticals has filed 10 recent SEC filings, including 4 Form 3, 2 Form SCHEDULE 13D/A, 2 Form 20-F, 2 Form 6-K. The most recent filing was submitted on May 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CASIF SEC filings →
Financial Highlights
Casi Pharmaceuticals generated $20.7M in revenue over the trailing twelve months, retaining a 48.6% gross margin, operating income reached -$45.0M (-217.3% operating margin), and net income was -$48.1M, reflecting a -232.0% net profit margin. Diluted earnings per share stood at $-2.59. The company generated -$20.8M in operating cash flow. With a current ratio of 0.27, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Casi Pharmaceuticals (CASIF) currently stands at 440.8 thousand shares, down 0.4% from the previous reporting period, representing 3.8% of the float. This relatively low short interest suggests limited bearish sentiment. With 43.4 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Casi Pharmaceuticals (CASIF) currently stands at 43.4 days, up 49.5% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 805.6% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 4.8 to 43.4 days.